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Primary Pulmonary Extranodal Natural Killer/T-cell Lymphoma, 
Nasal Type Presenting as Diffuse Ground Glass Opacities: a Case 
Report
Extranodal natural killer (NK)/T-cell lymphoma, nasal type (ENKTCL) is a rare type of 
lymphoma that accounts for only 5%–18% of all cases of non-Hodgkin lymphoma (NHL). 
In published series, 60%–90% of NK/T-cell lymphomas are localized to the nasal and upper 
airway. We describe a 55-year man who presented with cough, sputum, dyspnea on 
exertion, and a chest computed tomography scan shows diffuse ground glass opacities 
(GGOs), suggestive of an interstitial lung disease. He was treated with a corticosteroid and 
his symptoms improved. However, when the corticosteroid was tapered, his symptoms 
recurred. The patient underwent a surgical lung biopsy and ENKTCL was diagnosed. We 
present this case because ENKTCL involving only the lung is very rare but very informative. 
To our knowledge, our patient is the first case that primary pulmonary ENKTCL is presented 
with GGOs.
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INTRODUCTION
Extranodal natural killer (NK)/T-cell lymphoma, nasal type 
(ENKTCL) is a rare entity of non-Hodgkin lymphoma (NHL) 
that typically involves the nasal cavity and upper aerodigestive 
tract. However, it can also occur at extranasal sites (the skin, liv-
er, spleen, gastrointestinal tract, bone marrow, lung, and so on). 
A primary presentation of ENKTCL in the lung and ENKTCL 
involving only the lung is rare (1,2). Furthermore, there is no re-
port which primary pulmonary ENKTCL is presented with ground 
glass opacities (GGOs). Here, we describe a case of primary pul-
monary ENKTCL presenting with pulmonary symptoms and 
GGOs.
CASE DESCRIPTION
A 55-year-old man without any past medical history presented 
with cough, sputum, and dyspnea on exertion for three months 
in March, 2015. He had a smoking history of 30 pack-years, and 
had quit smoking since his dyspnea developed. On physical ex-
amination, he appeared acutely ill, and lung sounds were de-
creased in bilateral lung fields. He had no peripheral lymphade-
nopathy, organomegaly, or skin lesion. Laboratory findings were 
within normal ranges, except for mild elevations of aspartate 
transaminase (AST) and alanine transaminase (ALT) (AST, 50 
IU/L; ALT, 54 IU/L). An arterial blood gas analysis showed mild 
hypoxia (partial pressure of arterial oxygen, 60.3 mmHg; partial 
pressure of arterial carbon dioxide, 31.0 mmHg; and pH, 7.455). 
The result of a pulmonary function test shows decreased diffus-
ing capacity of the lungs for carbon monoxide (DLCO; 5.02 mmol/ 
min/kPa [58.66% of the predicted value]), forced vital capacity 
(FVC; 3.15 L [85.74% of the predicted value]), forced expiratory 
volume in 1 second (FEV1; 2.31 L [77.71% of the predicted val-
ue]), and a ratio of FEV1/FVC (73.15).
 His initial computed tomography (CT) scan shows diffuse 
GGOs in both lungs with underlying emphysema (Fig. 1). Bron-
choalveolar lavage (BAL) and transbronchial lung biopsy (TBLB) 
via a flexible fiberoptic bronchoscope were performed. The BAL 
fluid contained 55% lymphocytes with a CD8/CD4 ratio of 1:1, 
7% eosinophils, and pathology obtained from the TBLB showed 
multifocal interstitial and perivascular inflammatory infiltrates, 
which were predominantly lymphocytes. There was no evidence 
of infection in the results of TBLB and BAL. Although the pa-
thology results were not diagnostic, and definite exposure to a 
known offending antigen did not exist, interstitial lung disease 
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tive interstitial pneumonia (DIP) was highly suggested based 
on the results of the CT scan. With the impression of ILD, he was 
treated with a corticosteroid (prednisolone 60-mg daily; Cima 
Labs Inc., Eden Prairie, MN, USA). His symptoms and imaging 
were improved at the beginning of corticosteroid treatment, but 
when the corticosteroid was tapered, his symptoms recurred 
and his imaging worsened. After three months of corticosteroid 
treatment, he took a follow-up CT scan and it shows diffuse GGOs 
aggravated compared to initial CT scan (Fig. 1). Therefore, the 
patient underwent wedge resections of the lung under video-
assisted thoracoscopic surgery (VATS) for a definite diagnosis. 
Wedge resections were done at lateral segment of right middle 
lobe and posterior basal segment of right lower lobe. The speci-
men revealed diffuse lymphomatous infiltration, which was 
composed of medium-sized cells. Immunohistochemically, these 
cells showed positivity for CD56, granzyme B, CD2, and loss of 
surface CD3 expression. In situ hybridization for Epstein-Barr 
virus (EBV) encoded small nuclear RNAs (EBERs) was positive 
(Fig. 2). The pathology result was consistent with ENKTCL. Since 
most ENKTCL originates from the nose and paranasal area, in-
cluding the upper aerodigestive tract, the patient underwent a 
further imaging work-up (paranasal sinus CT, neck CT, and pos-
itron emission tomography-CT [PET-CT]) after pathologic con-
firmation, even though he did not have any symptom or sign of 
nose or paranasal area involvement (3,4). PET-CT scan showed 
no significant fluorodeoxyglucose (FDG) uptake to suggest ma-
lignancy (Fig. 3). The only organ that ENKTCL involved was the 
lung. The patient was treated with cyclophosphamide, doxoru-
bicin, vincristine, and prednisolone (CHOP) chemotherapy.
DISCUSSION
This report concerns a patient with ENKTCL without other in-
volvement, except for the lung, who was suspected as having 
ILD at the initial visit. ENKTCL commonly presents with mid-
line facial destructive disease and shows a strong association 
with EBV (5). It occurs typically within the nasal cavity and up-
per aerodigestive tract (3,4). ENKTCL arises in all geographic 
regions of the world, although it is much more common in Asian 
and Hispanic populations and rare in the USA and Europe (6).
 Most cases are derived from the malignant transformation of 
NK cells that express CD56+ and a lack of surface CD3 expres-
sion and T-cell receptor (TCR) gene rearrangements. More than 
80% of ENKTCL affects the nose and paranasal area, so the ini-
tial complaints of ENKTCL include local symptoms such as uni-
lateral nasal cavity obstruction with purulent discharge and bleed-
ing. Moreover, these symptoms can lead to early disease recog-
nition (7).
 However, ENKTCL can also occur predominantly at extrana-
sal sites, which makes it hard to diagnose. The sites of predilec-
tion of non-upper aerodigestive tract ENKTCL were the skin 
Fig. 1. Follow-up CT scan shows diffuse GGOs at both lungs with underlying emphy-
sema. Arrows indicate sites of wedge resections. Posterior basal segment of right 
lower lobe (A) and lateral segment of right middle lobe (B). (A, B) Axial view. (C) Coro-
nal view.




Song MJ, et al. • Primary Pulmonary NK/T Cell Lymphoma
http://jkms.org  1729https://doi.org/10.3346/jkms.2017.32.10.1727
Fig. 2. Histopathology of the lung biopsy. (A) Angio-
centric infiltration of the lung parenchyme (magnifi-
cation × 200). (B) Neoplastic cells stained for gran-
zyme B (magnification × 200). (C) Neoplastic cells 
stained for CD2 (magnification × 200). (D) Neoplastic 
cells with loss of expression for surface CD3 (magni-
fication × 200). (E) EBERs by in situ hybridization (mag-
nification × 100).







Fig. 3. PET-CT scan shows no significant FDG uptake to suggest malignancy. The lung 
where ENKTCL is confirmed by biopsy also shows no FDG uptake.
PET-CT = positron emission tomography-computed tomography, FDG = fluorodeoxy-
glucose, ENKTCL = extranodal natural killer/T-cell lymphoma, nasal type.
(37%), liver or spleen (31%), gastrointestinal tract (24%), bone 
marrow (22%), lung (14%), extremities (8%), and testis (5%) (3,4,8).
 When ENKTCL is suspected, a histopathological examina-
tion is necessary. The histopathology of ENKTCL comprises a 
mixed pattern ranging from small-to-medium sized atypical 
cells to large transformed cells. The tumor cells typically have 
the immunophenotype of CD56+, CD2+, cytoplasmic CD3+, 
and are negative to other T-cell antigens such as surface CD3, 
CD4, CD5, CD57, CD16, and B-cell antigens such as CD20. In 
addition, cytotoxic molecules such as granzyme B and T-cell 
intracellular antigen-1 (TIA-1) (76.2% of all ENKTCL), perforin, 
and the nm23-HI gene (42% of all ENKTCL) can be expressed 
in this type of lymphoma. ENKTCL seems to be caused by EBV, 
and EBER in situ hybridization is the most reliable way to dem-
onstrate the presence of EBV, which can be achieved from par-
affin-embedded tissues (4,7-9).
 ENKTCL is rare, and has been recognized as an independent 
disease relatively recently; thus, the optimal therapeutic appro-
ach and prognosis have not been fully defined yet. However, this 
entity is generally known to have an aggressive clinical course, 
and standard NHL treatment consisting of anthracycline-based 
chemotherapy is unsatisfactory (10).
 The chest CT patterns of ENKTCL with lung involvement seems 
to be variable. In the previous reviews of ENKCL patients with 
lung involvement, patchy consolidations, nodules, and masses 
are the most frequent chest CT findings. GGOs are relatively 
rare and may represent an early stage of disease that develops 
into consolidations at the end stage (1,11-13).
 We present this case because primary pulmonary ENKTCL is 
rare and chest CT finding of GGOs is especially rare. To our knowl-
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edge, our case is the first case that primary pulmonary ENKTCL 
is presented with GGOs. Clinicians should know that ENKTCL 
can involve only the lung and can present as GGOs in CT scan. 
Surgical lung biopsy should be considered when the clinical 
course is not according to initial impression.
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